创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Research Progress of Antibody Drugs Targeting Epidermal Growth Factor Receptor
WANG Pengfei, ZHANG Lingli, SONG Ge, ZHANG Juan
2024, 48(11): 801-812. DOI: 10.20053/j.issn1001-5094.2024.11.001
Abstract PDF
Advances in Research on the Role of Liver Sinusoidal Endothelial Cell in Liver Diseases and Related Therapeutic Drugs
QIAN Jialong, ZHOU Mengze, HU Qinghua
2024, 48(11): 813-822. DOI: 10.20053/j.issn1001-5094.2024.11.002
Abstract PDF
Advances in Research on Micropeptides Encoded by Long Non-coding RNAs
ZHANG Xue, LI Chencheng, WANG Ying
2024, 48(11): 823-837. DOI: 10.20053/j.issn1001-5094.2024.11.003
Abstract PDF
Research Advances on Pathogenesis of Liver Fibrosis and Related Therapeutic Drugs
GUO Feiyu, WANG Duowei
2024, 48(11): 838-848. DOI: 10.20053/j.issn1001-5094.2024.11.004
Abstract PDF
Research Progress of Traditional Chinese Medicine in the Prevention and Treatment of Nonalcoholic Fatty Liver Disease Based on the “Gut-liver Axis”
CHEN Huan, XU Luzhou, HUANG Fang
2024, 48(11): 849-859. DOI: 10.20053/j.issn1001-5094.2024.11.005
Abstract PDF
Research Progress of Reactive Oxygen Species-Responsive Drug Delivery Systems in Anti-inflammatory Therapy
LI Pengcheng, YANG Yanrui, DU Yuhang, JIAO Yu, HUANG Qiuying, ZHANG Huihui, ZHANG Qixiong, LI Shanshan
2024, 48(11): 860-867. DOI: 10.20053/j.issn1001-5094.2024.11.006
Abstract PDF
Clinical Research Progress of Antibody Drugs for Pediatric Crohn's Disease
CAI Mingyuan, HU Changping, LUO Ping
2024, 48(11): 868-附页2. DOI: 10.20053/j.issn1001-5094.2024.11.007
Abstract PDF